mRNA Platform Technology - SmartCap / STLNP

1. Generic ST Pharm focusing on technical challenging and brand generics. We specialize in MRI contrast agents and and possess a portfolio of tuberculosis and anti-infectious drugs as generic APIs. 2. Monomer ST Pharm offers a one-stop service from nucleosides to phosphoramidites with specialty and commo...

ST Pharm provides mRNA CDMO service from custom mRNA IVT synthesis to lipid nanoparticle (LNP) formulation with its own IP on two key mRNA platform technologies, SmartCap (proprietary 5'-capping) and STLNP (LNP with novel ionizable lipid). We are able to manufacture in GMP/non-GMP grade, and able to suppo...

ST Pharm offers top-tier customized oligonucleotide CDMO services under stringent cGMP conditions. We enhance raw material supply chain resilience by leveraging in-house manufacturing capabilities of nucleosides/phosphormaidites. Our two state-of-the-art facilities, expected to reach a 7.0 mol capacity b...

ST Pharm has a strong track record in small molecule CDMO services with over 30 years of experience. We came from a history of being the wolrd largest supplier of Thymidine (DT) to GSK and BMS and 1st HIV/AIDS drug (Zidovudine) to GSK. Over 20 small molecule programs up and running through two manufacturi...

The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025

ST Pharm, we are the innovative company saving lives. As a reliable CDMO partner, ST Pharm offers comprehensive contract development and manufacturing services. As your trusted partner, we will take you on a journey to explore the core values and capabilities that define our company.